SCHEMBL20564787

SCHEMBL20564787

O=c1cc(-c2ccccc2)c2cccnc2n1Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
LDHA P00338 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
HTT P42858 2/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
BRD4 O60885 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3517696 0.81 ALDH1A1 (0.40) HSD17B10ALDH1A1TSHRCYP2C19HTT
SCHEMBL4460861 0.77 FEN1 (0.47) HSD17B10ALDH1A1TSHRCYP2C19LDHA
SCHEMBL8696587 0.77 HSD17B10 (0.60) HSD17B10ALDH1A1TSHRCYP2C19ADORA1
SCHEMBL8691780 0.76 ALDH1A1 (0.58) HSD17B10ALDH1A1TSHRCYP2C19LDHA
SCHEMBL8692262 0.75 HSD17B10 (0.47) HSD17B10ALDH1A1TSHRCYP2C19LDHA
SCHEMBL8691517 0.74 HSD17B10 (0.46) HSD17B10ALDH1A1TSHRCYP2C19ADORA2A
SCHEMBL8691911 0.74 LMNA (0.42) HSD17B10ALDH1A1TSHRCYP2C19LDHA
SCHEMBL8691464 0.73 HSD17B10 (0.41) HSD17B10ALDH1A1TSHRCYP2C19LDHA
SCHEMBL3519074 0.73 PIK3CD (0.44) ALDH1A1TSHRHTTCCNE1CDK2
SCHEMBL8695153 0.72 HSD17B10 (0.47) HSD17B10ALDH1A1ADORA2ACCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12502362-B2 Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics SAINT LOUIS UNIVERSITY (US) 2025-12-23 US disclosed
US-20200147086-A1 INHIBITORS OF NUCLEOTIDYLTRANSFERASE SUPERFAMILY ENZYMES AS ANTIBIOTICS SAINT LOUIS UNIVERSITY (US) 2020-05-14 US disclosed
WO-2018213378-A1 INHIBITORS OF NUCLEOTIDYLTRANSFERASE SUPERFAMILY ENZYMES AS ANTIBIOTICS SAINT LOUIS UNIVERSITY (US) 2018-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12502362-B2 Inhibitors of nucleotidyltransferase superfamily enzymes as antibiotics DNTT, APRT, RNGTT HSD17B10 1539/4885ALDH1A1 1388/4885TSHR 2836/4885
US-20200147086-A1 INHIBITORS OF NUCLEOTIDYLTRANSFERASE SUPERFAMILY ENZYMES AS ANTIBIOTICS DNTT, APRT, RNGTT HSD17B10 1539/4885ALDH1A1 1388/4885TSHR 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.